Sanofi-Aventis has a new CFO, starting next week: Jerome Contamine, a former exec at Veolia Environment, will move into the finance office as of March 16.
Evotec has elected Dr. Werner Lanthaler as its CEO.
ANI Pharmaceuticals has appointed Arthur Przybyl as CEO of the company.
CG Therapeutics has named Denise Harrison as its new chief executive officer and president. Harrison previously held the position of CFO and takes over for Jonathan Green, CGT's first CEO, "in an effort to move the company forward in new directions."
Uluru announced that Kerry P. Gray resigned as CEO. Renaat Van den Hooff has been appointed by the board of directors to assume the position.
Catalent Pharma Solutions has named John Chiminski as president and CEO.
Neugenesis has named Michael J. Buckley, Ph.D. as COO. Buckley joined Neugenesis from Genitope, where he was former vice president of manufacturing.
Enzo Biochem announced that its Enzo Clinical Labs subsidiary has appointed Kevin Krenitsky as its new president.
Advanced Proteome Therapeutics appointed Kenneth Phillippe as chief financial officer, replacing Alexander Krantz. Krantz will remain as president, CEO and secretary of the company.
China-Biotics said that Lewis Fan will succeed Raymond Li as CFO.
DiaMedica appointed Stephen Waters as interim executive vice president and chief scientific officer.
Merrimack Pharmaceuticals has promoted Ulrik B. Nielsen senior vice president and chief scientific officer and Edward (Tad) J. Stewart to senior vice president of business development.
aTyr Pharma announced that Dr. James Cai has joined the company as senior vice president of clinical development and president of Pangu BioPharma, a fully owned aTyr Pharma subsidiary in Hong Kong.
AcelRx Pharmaceuticals has hired Mark Evashenk as vice president, clinical operations.
BASi said that two additional business development representatives will work out of BASi's facility in the United Kingdom and Jack Polidoro, Ph.D., will focus on the Evansville, Indiana operation.
The X PRIZE Foundation named Patrick Soon-Shiong, M.D., as chairman of its Life Sciences Prize Group Steering Committee.
Pure Bioscience has named John J. Carbone, MD, to the board of directors.